Unraveling the skin microbiome’s impact on aging

The effects of aging and external factors like UV exposure on skin are well documented. As people age or spend more time in the sun, their skin tends to become drier and more wrinkled,

Cybin Initiates Dosing of Final Cohort of its Phase 2 Trial of CYB003 in Major Depressive Disorder | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN / NEO:CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, today announced that

August 4, 2023

FDA OKs the first-ever self-administered vaccine, for flu

Americans can now vaccinate themselves against the flu without the assistance of a healthcare worker. For the first time, the FDA Sign up to read

September 21, 2024

Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board | Psychedelic Invest

Clearmind Medicine Inc. (Nasdaq, CSE: CMND / FSE: CWY) a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.